The panel convened to assess if the current labels effectively explain the upsides and downsides of taking fluoroquinolones to treat sinus infections, urinary-tract infections (UTIs), and bronchitis that aggravates existing chronic obstructive pulmonary disease (COPD).
These antibiotics belong...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.